[DNLI] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -131.12%
YoY- -147.24%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 52,480 22,939 5,847 4,197 1,648 0 0 -
PBT -58,767 -60,691 -58,679 -58,650 -54,724 -22,134 -18,344 21.40%
Tax 27 728 79 -313 0 0 0 -
NP -58,794 -60,691 -58,758 -58,337 -54,724 -22,134 -18,344 21.41%
Tax Rate - - - - - - - -
Total Cost 111,274 83,630 64,605 62,534 56,372 22,134 18,344 35.02%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -112.03 -264.58 -1,004.93 -1,389.97 -3,320.63 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.48 -0.50 -0.56 -0.61 -0.59 -0.32 -3.37 -27.72%
EPS Diluted -0.48 -0.49 -0.56 -0.61 -0.59 -0.32 -3.37 -27.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.